This page provides general information only and does not make specific medicinal, cosmetic, or therapeutic claims
Without controlled studies, we cannot know whether observed improvements result from the treatment itself, placebo effects, natural weight fluctuation, or simple photograph manipulation
The United States Pharmacopeia (USP) standards for injectable peptides require sterility testing, endotoxin (LAL) testing, and identity confirmation by HPLC or mass spectrometry
Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled Phase 3 trials with safety extension data